首页> 美国卫生研究院文献>Heliyon >Synthesis DFT studies molecular docking antimicrobial screening and UV fluorescence studies on ct-DNA for novel Schiff bases of 2-(1-aminobenzyl) benzimidazole
【2h】

Synthesis DFT studies molecular docking antimicrobial screening and UV fluorescence studies on ct-DNA for novel Schiff bases of 2-(1-aminobenzyl) benzimidazole

机译:2-(1-氨基苄基)苯并咪唑新型席夫碱的ct-DNA的合成DFT研究分子对接抗菌筛选和UV荧光研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Novel Schiff bases (SBs) were synthesized by condensation of 2-(1-Amino benzyl) benzimidazole with heterocyclic and aromatic carbonyl compounds. The structural characterization was done using 1H, 13C NMR, FTIR and ES-MS spectroscopic techniques. The in silico pharmacokinetics showed that nearly all compounds obeyed Lipinski rule of 5 with low toxicity and metabolic stability. The global reactivity descriptors were calculated using DFT approach. The molecular docking result of SBs with ct-DNA suggested interaction via groove binding mode. The antibacterial activity was tested against S. aureus and E. coli, indicated significant inhibition than reference drug. The compound >4d gave best results at 50 μg ml−1 concentrations. UV/Vis and Fluorescence spectroscopy tools were used to evaluate ct-DNA binding ability of compounds >4a–e through hypochromic shift. The steady state fluorescence predicted a moderate binding constant of 1.12 × 104 for >4d, indicative of non-intercalative mode.
机译:通过2-(1-氨基苄基)苯并咪唑与杂环和芳香族羰基化合物的缩合反应合成了新型席夫碱(SBs)。使用 1 H, 13 C NMR,FTIR和ES-MS光谱技术进行结构表征。电子计算机药代动力学显示,几乎所有化合物均符合Lipinski 5规则,且毒性低且代谢稳定。全局反应性描述符是使用DFT方法计算的。 SBs与ct-DNA的分子对接结果表明通过凹槽结合模式相互作用。测试了对金黄色葡萄球菌和大肠杆菌的抗菌活性,显示出比参考药物显着的抑制作用。化合物> 4d 在50μgml -1 浓度下效果最佳。使用紫外线/可见光和荧光光谱仪工具通过低色移评估化合物> 4a–e 的ct-DNA结合能力。稳态荧光预测> 4d 的中等结合常数为1.12×10 4 ,表明为非插入模式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号